Abstract
Objective. To identify characteristic clinical and anamnestic features in patients with various proliferative endometrial diseases. Materials and Methods. A retrospective study was conducted involving 176 patients diagnosed with endometrial polyp (EP, n=58), endometrial hyperplasia without atypia (EH, n=52), endometrial hyperplasia with atypia (EHA, n=24), and endometrial cancer (EC, n=42). Data were analyzed based on medical history, clinical presentation, gynecological status, and somatic health. Statistical analysis was performed using the χ² test, Mann-Whitney test, and Kruskal-Wallis test. Results. The mean age of patients progressively increased across the groups: EP (45.3±0.9 years) → EH (46.6±1.2 years) → EHA (53.8±2.5 years) → EC (67.7±1.7 years). Heavy menstrual bleeding was noted in patients with EP (60.4%), while abnormal uterine bleeding was typical for EH (46.2%), and postmenopausal bleeding was predominant in EC (85.7%). In patients with EHA, a notable association was observed with multiple intrauterine interventions (75%), alongside high rates of infertility (12.5%) and recurrent miscarriage (8.4%). Women with EP more frequently presented with chronic pelvic inflammatory disease (24.1%) and anemia (39.7%); those with EH had a higher incidence of functional ovarian cysts (44.2%) and varicose veins of the lower extremities (21.1%); patients with EHA commonly exhibited obesity (37.5%) and gastrointestinal diseases (37.5%); and individuals with EC frequently had cardiovascular diseases (88.1%) and obesity (26.2%). Conclusion. Statistically significant differences were identified in the clinical and anamnestic characteristics of women with proliferative endometrial diseases. The key markers include the patient's age and the type of uterine bleeding.